JP2021113190A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021113190A5 JP2021113190A5 JP2021012521A JP2021012521A JP2021113190A5 JP 2021113190 A5 JP2021113190 A5 JP 2021113190A5 JP 2021012521 A JP2021012521 A JP 2021012521A JP 2021012521 A JP2021012521 A JP 2021012521A JP 2021113190 A5 JP2021113190 A5 JP 2021113190A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- antibody
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862657172P | 2018-04-13 | 2018-04-13 | |
| US62/657,172 | 2018-04-13 | ||
| EP18208332 | 2018-11-26 | ||
| EP18208332.9 | 2018-11-26 | ||
| JP2019562323A JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562323A Division JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021113190A JP2021113190A (ja) | 2021-08-05 |
| JP2021113190A5 true JP2021113190A5 (enExample) | 2022-04-15 |
Family
ID=66542473
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562323A Expired - Fee Related JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
| JP2021012521A Pending JP2021113190A (ja) | 2018-04-13 | 2021-01-28 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562323A Expired - Fee Related JP6861301B2 (ja) | 2018-04-13 | 2019-04-11 | 移植片拒絶の予防に使用するための抗ｃｄ４０抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11780927B2 (enExample) |
| EP (1) | EP3774913A1 (enExample) |
| JP (2) | JP6861301B2 (enExample) |
| KR (1) | KR20200143718A (enExample) |
| CN (1) | CN111971307A (enExample) |
| AU (1) | AU2019252858A1 (enExample) |
| BR (1) | BR112020020277A2 (enExample) |
| CA (1) | CA3094600A1 (enExample) |
| CL (1) | CL2020002622A1 (enExample) |
| IL (1) | IL277828A (enExample) |
| MX (1) | MX2020010722A (enExample) |
| TW (1) | TW201943731A (enExample) |
| WO (1) | WO2019198019A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020267953A1 (en) * | 2019-05-08 | 2021-11-18 | Novartis Ag | Anti-CD40 antibodies for use in treatment of T1DM and insulitis |
| JP2023538105A (ja) * | 2020-08-21 | 2023-09-06 | ウーシー・バイオロジクス・（シャンハイ）・カンパニー・リミテッド | Ｃｄ４０アゴニスト抗体及び使用方法 |
| JP2023548812A (ja) * | 2020-10-26 | 2023-11-21 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 免疫抑制剤の曲線下面積を評価する方法ならびに関連する方法及びシステム |
| CN118234749A (zh) * | 2021-09-17 | 2024-06-21 | 诺华股份有限公司 | 用于预防异种移植中的移植物排斥的方法 |
| KR20260116248A (ko) * | 2023-11-28 | 2026-07-28 | 엘레던 파마슈티컬즈, 아이엔씨. | 이식 거부반응 예방을 위한 방법 및 조성물 |
| US20250277048A1 (en) | 2024-03-01 | 2025-09-04 | Regeneron Pharmaceuticals, Inc. | The use of cd40 inhibitors for inhibiting an immune response and enabling immunogen administration and re-administration |
| WO2025184567A1 (en) | 2024-03-01 | 2025-09-04 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody response |
| WO2025235670A1 (en) | 2024-05-07 | 2025-11-13 | Eledon Pharmaceuticals, Inc. | Use of anti-cd40 ligand antibodies for immunosuppression in islet cell transplantation |
| WO2025235683A1 (en) * | 2024-05-07 | 2025-11-13 | Eledon Pharmaceuticals, Inc. | Methods and compositions for prevention of transplant rejection |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
| EP1707627B1 (en) | 2003-12-25 | 2012-11-14 | Kyowa Hakko Kirin Co., Ltd. | Antagonistic anti-CD40 antibody mutant |
| RU2006141632A (ru) * | 2004-04-27 | 2008-06-10 | Новартис Вэксинес Энд Дайэгностикс, Инк. (Us) | Антагонистические моноклональные анти-cd40-антитела и способы их применения |
| EP1854810A1 (en) | 2006-05-09 | 2007-11-14 | PanGenetics B.V. | Deimmunized antagonistic anti-human CD40 monoclonal antibody from the ch5D12 antibody |
| EP2796467B1 (en) | 2010-03-31 | 2018-03-28 | Boehringer Ingelheim International GmbH | Anti-CD40 antibodies |
| AR083847A1 (es) | 2010-11-15 | 2013-03-27 | Novartis Ag | Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40 |
| US11780977B2 (en) * | 2020-08-10 | 2023-10-10 | Dover Chemical Corporation | Polymer compositions having an improved printable surface and related methods |
-
2019
- 2019-04-11 JP JP2019562323A patent/JP6861301B2/ja not_active Expired - Fee Related
- 2019-04-11 CN CN201980024663.8A patent/CN111971307A/zh active Pending
- 2019-04-11 US US17/046,684 patent/US11780927B2/en active Active
- 2019-04-11 EP EP19724250.6A patent/EP3774913A1/en not_active Withdrawn
- 2019-04-11 AU AU2019252858A patent/AU2019252858A1/en not_active Abandoned
- 2019-04-11 WO PCT/IB2019/052976 patent/WO2019198019A1/en not_active Ceased
- 2019-04-11 CA CA3094600A patent/CA3094600A1/en active Pending
- 2019-04-11 TW TW108112758A patent/TW201943731A/zh unknown
- 2019-04-11 MX MX2020010722A patent/MX2020010722A/es unknown
- 2019-04-11 BR BR112020020277-0A patent/BR112020020277A2/pt not_active Application Discontinuation
- 2019-04-11 KR KR1020207032429A patent/KR20200143718A/ko not_active Withdrawn
-
2020
- 2020-10-06 IL IL277828A patent/IL277828A/en unknown
- 2020-10-09 CL CL2020002622A patent/CL2020002622A1/es unknown
-
2021
- 2021-01-28 JP JP2021012521A patent/JP2021113190A/ja active Pending
-
2023
- 2023-09-01 US US18/459,922 patent/US20240287198A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gorantla et al. | Immunosuppressive agents in transplantation: Mechanisms of action and current anti‐rejection strategies | |
| Lebranchu et al. | Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF‐containing triple therapy | |
| JP5722524B2 (ja) | 補体活性を抑制することによる同種移植片の生存の延長 | |
| US20110177027A1 (en) | COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha | |
| US20170267751A1 (en) | Prolongation of survival of an allograft by inhibiting complement activity | |
| EP0932415A1 (en) | Method of preventing acute rejection following solid organ transplantation | |
| US6214342B1 (en) | Method for increasing mean survival times of transplants with LFA-1-specific antibodies | |
| US20240287198A1 (en) | Anti-cd40 antibodies for use in prevention of graft rejection | |
| KR20030034177A (ko) | 허혈성 질환 치료제 | |
| CN105251004A (zh) | 在诊断和治疗类风湿性关节炎中使用的包含抗-cd6单克隆抗体的药物组合物 | |
| JPS6256440A (ja) | 不要細胞の分解あるいは阻止物質からなる治療剤 | |
| US8435520B2 (en) | Combinations of immunosuppressive agents for the treatment or prevention of graft rejections | |
| PT1737490E (pt) | Processos de tratamento da aterosclerose | |
| KR20080089645A (ko) | 암의 적출 장기 관류 병용 요법 | |
| RU2020137096A (ru) | Антитела к cd40 для применения в предотвращении отторжения трансплантата | |
| JP3168005B2 (ja) | 病気の処置 | |
| Tung et al. | Prolonged limb allograft survival with CD40 costimulation blockade, T‐cell depletion, and megadose donor bone‐marrow transfusion | |
| RU2021135507A (ru) | Антитела к cd40 для применения в лечении t1dm и инсулита | |
| CN118973600A (zh) | 用于脐带血移植后的血细胞恢复的药物组合物 | |
| KR20250120401A (ko) | 이식물 및 수혜자의 생존을 연장하기 위한 조성물 및 방법 | |
| Wills et al. | A Practical Approach to theUse of Intravenous Immunoglobulin in Neurological Disease | |
| HK40124218A (en) | Composition and method for prolong survival of transplant and recipient | |
| RU2020117365A (ru) | Антитела к cd40 для применения в лечении синдрома шегрена | |
| Walden | ORTHOCLONE OKT® 3 | |
| Kashyap et al. | Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: Complete report on 350 primary adult liver transplantations |